Abstract: A liquid medicine of the present invention comprising liquid having carbon dioxide dissolved therein, said liquid being administered by using means of liquid injection, and a method of treatment of the present invention using a liquid medicine comprising liquid having carbon dioxide dissolved therein, said liquid being administered by using means of liquid injection can reduce or eliminate tumors with few side effects. When the liquid medicine of the present invention comprising liquid having carbon dioxide dissolved therein, said liquid being administered by using means of liquid injection, and the method of treatment of the present invention using a liquid medicine comprising liquid having carbon dioxide dissolved therein, said liquid being administered by using means of liquid injection are used in combination with surgical therapy, chemotherapy, radiotherapy, or immunotherapy of tumors, effects can be enhanced or side effects can be reduced compared with monotherapy or multidisciplinary therapy thereof.
Type:
Application
Filed:
September 25, 2013
Publication date:
June 18, 2015
Applicants:
NEOCHEMIR INC., NATIONAL UNIVERSITY CORPORATION KOBE UNIVERSITY, CO2BE MEDICAL ENGINEERING K.K.
Abstract: The present invention provides a prophylactic or therapeutic agent for fracture and bone diseases as well as a bone growth promoting agent containing carbon dioxide as an active ingredient. Further, according to the present invention, an additive or synergistic effect for preventing or treating fracture and bone diseases as well as for promoting bone growth by combining the therapeutic agent of the present invention and a bone absorption inhibitor and/or a bone formation promoter is obtained.
Type:
Application
Filed:
July 13, 2012
Publication date:
May 8, 2014
Applicants:
NEOCHEMIR INC., NATIONAL UNIVERSITY CORPORATION KOBE UNIVERSITY, CO2BE MEDICAL ENGINEERING K.K.
Abstract: An antitumor agent comprising carbon dioxide as an active ingredient of the present invention can reduce the tumor volume or eradicate the tumor of a patient who is difficult to take a surgical therapy, a chemotherapy, a radiation therapy or an immunotherapy. The antitumor agent comprising carbon dioxide as an active ingredient of the present invention is useful because the agent enables (1) the reduction in size or elimination of a tumor, (2) the suppression of tumor metastasis and also (3) the reduction in volume or elimination of a tumor at a part different from the part where carbon dioxide is transdermally absorbed by the transdermal absorption of carbon dioxide through the skin near the tumor or the skin far from the tumor.
Type:
Application
Filed:
March 22, 2012
Publication date:
January 16, 2014
Applicants:
NEOCHEMIR INC., NATIONAL UNIVERSITY CORPORATION KOBE UNIVERSITY, CO2BE MEDICAL ENGINEERING K.K.